| Primary |
| Depression |
33.3% |
| Hypertension |
33.3% |
| Neutropenia |
33.3% |
|
| Renal Failure Acute |
100.0% |
|
| Secondary |
| Prophylaxis |
11.9% |
| Sarcoma Uterus |
11.4% |
| Product Used For Unknown Indication |
10.9% |
| Diffuse Large B-cell Lymphoma |
9.2% |
| Infection Prophylaxis |
9.1% |
| B-cell Lymphoma |
7.1% |
| Drug Use For Unknown Indication |
4.9% |
| Acute Lymphocytic Leukaemia |
4.8% |
| Multiple Myeloma |
4.6% |
| Sarcoma |
4.4% |
| Acute Myeloid Leukaemia |
3.0% |
| Bone Marrow Conditioning Regimen |
3.0% |
| T-cell Lymphoma |
2.3% |
| Prophylaxis Against Graft Versus Host Disease |
2.1% |
| Hypertension |
2.0% |
| Peripheral T-cell Lymphoma Unspecified |
2.0% |
| Prophylaxis Of Nausea And Vomiting |
2.0% |
| Pyrexia |
2.0% |
| Neutropenia |
1.8% |
| Acute Myeloid Leukemia |
1.6% |
|
| Off Label Use |
9.5% |
| Sepsis |
8.1% |
| Malignant Melanoma In Situ |
6.8% |
| Transaminases Increased |
6.8% |
| White Blood Cell Count Decreased |
6.8% |
| Febrile Neutropenia |
5.4% |
| Neutropenia |
5.4% |
| Pleural Effusion |
5.4% |
| Septic Shock |
5.4% |
| Tachycardia |
5.4% |
| Vomiting |
5.4% |
| Pyrexia |
4.1% |
| Splenic Rupture |
4.1% |
| Stomatitis |
4.1% |
| Thrombocytopenia |
4.1% |
| Anaemia |
2.7% |
| Death |
2.7% |
| General Physical Health Deterioration |
2.7% |
| Generalised Erythema |
2.7% |
| Haematuria |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.2% |
| Prophylaxis |
10.8% |
| Infection Prophylaxis |
8.1% |
| Aplastic Anaemia |
5.7% |
| Premedication |
5.6% |
| Bone Marrow Conditioning Regimen |
5.0% |
| Prophylaxis Against Graft Versus Host Disease |
4.1% |
| Antifungal Prophylaxis |
3.9% |
| Drug Use For Unknown Indication |
3.9% |
| B-cell Lymphoma |
3.0% |
| Acute Lymphocytic Leukaemia |
2.7% |
| Diffuse Large B-cell Lymphoma |
2.6% |
| Graft Versus Host Disease |
2.2% |
| Acute Myeloid Leukaemia |
2.1% |
| Hypertension |
2.1% |
| Antiviral Prophylaxis |
1.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
| Constipation |
1.5% |
| Insomnia |
1.5% |
| Antibiotic Prophylaxis |
1.5% |
|
| Pneumothorax |
13.8% |
| White Blood Cell Count Decreased |
11.3% |
| Thrombocytopenia |
7.7% |
| Febrile Neutropenia |
6.8% |
| Pyrexia |
6.1% |
| Vomiting |
6.1% |
| Staphylococcal Sepsis |
5.5% |
| Pneumonia |
4.5% |
| Stomatitis |
4.5% |
| Pancytopenia |
4.2% |
| Fungal Infection |
3.9% |
| Renal Failure Acute |
3.9% |
| Septic Shock |
3.5% |
| Staphylococcal Infection |
3.2% |
| Respiratory Failure |
2.9% |
| Sepsis |
2.9% |
| Neutropenia |
2.6% |
| Cytomegalovirus Infection |
2.3% |
| Diarrhoea |
2.3% |
| Multi-organ Failure |
2.3% |
|
